DOCSLIB.ORG

Shengjing Bank Co., Ltd.* (A Joint Stock Company Incorporated in the People's Republic of China with Limited Liability) Stock Code: 02066 Annual Report Contents

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Shengjing Bank Co., Ltd.* (A Joint Stock Company Incorporated in the People's Republic of China with Limited Liability) Stock Code: 02066 Annual Report Contents Shengjing Bank Co., Ltd.* (A joint stock company incorporated in the People's Republic of China with limited liability) Stock Code: 02066 Annual Report Contents 1. Company Information 2 8. Directors, Supervisors, Senior 68 2. Financial Highlights 4 Management and Employees 3. Chairman’s Statement 7 9. Corporate Governance Report 86 4. Honours and Awards 8 10. Report of the Board of Directors 113 5. Management Discussion and 9 11. Report of the Board of Supervisors 121 Analysis 12. Social Responsibility Report 124 5.1 Environment and Prospects 9 13. Internal Control 126 5.2 Development Strategies 10 14. Independent Auditor’s Report 128 5.3 Business Review 11 15. Financial Statements 139 5.4 Financial Review 13 16. Notes to the Financial Statements 147 5.5 Business Overview 43 17. Unaudited Supplementary 301 5.6 Risk Management 50 Financial Information 6. Significant Events 58 18. Organisational Chart 305 7. Change in Share Capital and 60 19. The Statistical Statements of All 306 Shareholders Operating Institution of Shengjing Bank 20. Definition 319 * Shengjing Bank Co., Ltd. is not an authorised institution within the meaning of the Banking Ordinance (Chapter 155 of the Laws of Hong Kong), not subject to the supervision of the Hong Kong Monetary Authority, and not authorised to carry on banking and/or deposit-taking business in Hong Kong. COMPANY INFORMATION Legal Name in Chinese 盛京銀行股份有限公司 Abbreviation in Chinese 盛京銀行 Legal Name in English Shengjing Bank Co., Ltd. Abbreviation in English SHENGJING BANK Legal Representative ZHANG Qiyang Authorised Representatives ZHANG Qiyang and ZHOU Zhi Secretary to the Board of Directors ZHOU Zhi Joint Company Secretaries ZHOU Zhi and KWONG Yin Ping, Yvonne Registered and Business Address No. 109 Beizhan Road, Shenhe District, Shenyang, Liaoning Province, the PRC Contact Number 86–24–22535633 Website www.shengjingbank.com.cn Principal Place of Business in Hong Kong Unit 3209, 32/F, Office Tower, Convention Plaza, 1 Harbour Road, Wanchai, Hong Kong Website of the Hong Kong Stock Exchange www.hkexnews.hk on which the H Share Annual Report is Published Place of Maintenance of the Annual Report Office of the Board of Directors of Shengjing Bank Stock Name Shengjing Bank 2 Shengjing Bank Co., Ltd. COMPANY INFORMATION (CONTINUED) Stock Code 02066 Share Registrar and its Business Address Computershare Hong Kong Investor Services Limited Shops 1712–1716, 17th Floor, Hopewell Centre 183 Queen’s Road East, Wanchai, Hong Kong Legal Advisor as to PRC Laws and its Tian Yuan Law Firm Business Address 10/F, China Pacific Insurance Plaza 28 Fengsheng Hutong Xicheng District Beijing, the PRC Legal Advisor as to Hong Kong Law and its Freshfields Bruckhaus Deringer Business Address 55th Floor, One Island East, Taikoo Place Quarry Bay, Hong Kong Auditor and its Business Address KPMG 8th Floor, Prince’s Building 10 Chater Road Hong Kong Annual Report 2018 3 FINANCIAL HIGHLIGHTS Year-on- year change (Expressed in thousands of between Renminbi, unless otherwise stated) 2018 2017 2018 and 2017 2016 2015 2014 Rate of change (%) Operating Results Interest income 42,805,495 42,277,528 1.2 36,055,533 31,479,529 25,415,004 Interest expense (30,387,931) (30,201,911) 0.6 (22,837,867) (19,530,998) (15,513,832) Net interest income 12,417,564 12,075,617 2.8 13,217,666 11,948,531 9,901,172 Net fee and commission income 626,699 1,612,758 (61.1) 1,913,907 1,204,189 1,368,431 Net trading gains/(losses), net gains/(losses) arising from investments, Net foreign exchange gains/(losses), other operating income 2,841,203 (438,692) N/A 982,303 1,031,436 (64,840) Operating income 15,885,466 13,249,683 19.9 16,113,876 14,184,156 11,204,763 Operating expenses (3,945,215) (3,617,442) 9.1 (3,730,598) (4,102,162) (3,211,887) Impairment losses on assets (6,401,249) (1,403,284) 356.2 (3,675,411) (1,955,377) (934,151) Operating profit 5,539,002 8,228,957 (32.7) 8,707,867 8,126,617 7,058,725 Share of profits of associates – – – – – 2,338 Profit before taxation 5,539,002 8,228,957 (32.7) 8,707,867 8,126,617 7,061,063 Income tax expense (412,854) (654,818) (37.0) (1,829,575) (1,902,790) (1,637,225) Net profit 5,126,148 7,574,139 (32.3) 6,878,292 6,223,827 5,423,838 Net profit attributable to equity shareholders of the Bank 5,128,717 7,580,055 (32.3) 6,864,520 6,211,334 5,404,933 4 Shengjing Bank Co., Ltd. FINANCIAL HIGHLIGHTS (CONTINUED) Year-on- year change (Expressed in thousands of between Renminbi, unless otherwise stated) 2018 2017 2018 and 2017 2016 2015 2014 Change Calculated on a per share basis (RMB) Basic and diluted earnings per share 0.88 1.31 (0.43) 1.18 1.07 1.25 Dividend per share 0.12 0.18 (0.06) 0.25 (0.28) 0.275 Rate of change (%) Major indicators of assets/ liabilities Total assets 985,432,940 1,030,617,431 (4.4) 905,482,647 701,628,500 503,370,514 Of which: total loans and advances to customers(11) 376,597,360 279,513,418 34.7 235,416,650 195,460,365 158,644,499 Total liabilities 928,403,456 978,361,775 (5.1) 859,108,021 659,913,547 467,237,029 Of which: total deposits from customers(11) 514,166,997 473,580,808 8.6 415,246,159 402,379,086 315,943,789 Share capital 5,796,680 5,796,680 – 5,796,680 5,796,680 5,646,005 Equity attributable to equity shareholders of the Bank 56,457,868 51,681,375 9.2 45,794,429 41,268,528 35,699,553 Total equity 57,029,484 52,255,656 9.1 46,374,626 41,714,953 36,133,485 Change Profitability Indicators (%) Return on average total assets(1) 0.51 0.78 (0.27) 0.86 1.03 1.26 Return on average equity(2) 9.38 15.36 (5.98) 15.62 15.99 18.83 Net interest spread(3) 1.33 1.36 (0.03) 1.65 2.00 2.07 Net interest margin(4) 1.43 1.50 (0.07) 1.75 2.14 2.32 Net fee and commission income to operating income 3.95 12.17 (8.22) 11.88 8.49 12.21 Cost-to-income ratio(5) 24.13 26.22 (2.09) 19.31 19.04 19.06 Change Asset quality indicators (%) Non-performing loan ratio (6) 1.71 1.49 0.22 1.74 0.42 0.44 Allowance to non-performing loans (7) 160.81 186.02 (25.21) 159.17 482.38 387.42 Allowance to total loans (8) 2.75 2.77 (0.02) 2.78 2.01 1.70 Annual Report 2018 5 FINANCIAL HIGHLIGHTS (CONTINUED) Year-on- year change (Expressed in thousands of between Renminbi, unless otherwise stated) 2018 2017 2018 and 2017 2016 2015 2014 Change Capital adequacy indicators (%) Core Tier-one capital adequacy ratio(9) 8.52 9.04 (0.52) 9.10 9.42 11.04 Tier-one capital adequacy ratio (9) 8.52 9.04 (0.52) 9.10 9.42 11.04 Capital adequacy ratio (9) 11.86 12.85 (0.99) 11.99 13.03 12.65 Total equity to total assets ratio 5.79 5.07 0.72 5.12 5.95 7.18 Change Other indicators (%) Loan-to-deposit ratio (10) 73.24 59.02 14.22 56.69 48.58 50.21 Note: (1) Calculated by dividing the net profit by the average of total assets at the beginning and at the end of the period. (2) Representing the net profit during the period as a percentage of the average balance of total equity at the beginning and the end of the period. (3) Calculated by deducting the average interest rate of interest-bearing liabilities from the average return rate of interest-earning assets. (4) Calculated by dividing net interest income by the average interest-earning assets. (5) Calculated by dividing operating expenses (less tax and surcharges) by operating income. (6) Calculated by dividing the balance of non-performing loans by total balance of loans and advances to customers. (7) Calculated by dividing the balance of provision for impairment on loans by the balance of non-performing loans. (8) Calculated by dividing the balance of the provision for impairment on loans by the total balance of loans and advances to customers. (9) Core Tier-one capital adequacy ratio, core capital adequacy ratio and capital adequacy ratio were calculated in accordance with the latest guidance promulgated by the CBIRC (effective from 1 January 2013). (10) The loan-to-deposit ratio is calculated by dividing the total balance of loans and advances to customers by total deposits from customers. (11) Total balance of loans and advances to customers excludes interest receivables, total deposits from customers excludes interest payables. 6 Shengjing Bank Co., Ltd. CHAIRMAN’S STATEMENT The development environment of the banking industry was still challenging in 2018. Outside China, the global economy was in a complicated situation with its development and expected growth being handicapped and hindered by increasing uncertainties. Within China, under the background of the implementation of de-leveraging and enhanced regulation on domestic economy, both industrial enterprises and financial institutions were under the pressure of adjustment and transformation. Facing the change in the internal and external business environments, Shengjing Bank put forward new goals and transformation requirements, asking the entire Bank to make efforts to achieve its development target, namely, to develop itself into “a comprehensive, diversified and quality joint-stock commercial bank with a leading position among banks of the same type”.
Load more

Recommended publications
  • Corporate Information
    THIS DOCUMENT IS IN DRAFT FORM. THE INFORMATION CONTAINED HEREIN IS INCOMPLETE AND IS SUBJECT TO CHANGE. THIS DOCUMENT MUST BE READ IN CONJUNCTION WITH THE SECTION HEADED “WARNING” ON THE COVER OF THIS DOCUMENT. CORPORATE INFORMATION Head Office, Registered Office and No. 177-1, Chuangxin Road Principal Place of Business in the PRC Hunnan District Shenyang Liaoning Province the PRC Principal Place of Business in Hong Kong 40/F, Dah Sing Financial Centre 248 Queen’s Road East Wanchai Hong Kong Company’s Website www.neusoftmedical.com (information on this website does not form part of this Document) Joint Company Secretaries Mr. LI Feng (李峰) No. 177-1, Chuangxin Road Hunnan District Shenyang Liaoning Province the PRC Mr. CHENG Ching Kit (鄭程傑) (ACS, ACG) 40/F, Dah Sing Financial Centre 248 Queen’s Road East Wanchai Hong Kong Authorized Representatives Mr. WU Shaojie (武少傑) No. 177-1, Chuangxin Road Hunnan District Shenyang Liaoning Province the PRC Mr. CHENG Ching Kit (鄭程傑) (ACS, ACG) 40/F, Dah Sing Financial Centre 248 Queen’s Road East Wanchai Hong Kong –91– THIS DOCUMENT IS IN DRAFT FORM. THE INFORMATION CONTAINED HEREIN IS INCOMPLETE AND IS SUBJECT TO CHANGE. THIS DOCUMENT MUST BE READ IN CONJUNCTION WITH THE SECTION HEADED “WARNING” ON THE COVER OF THIS DOCUMENT. CORPORATE INFORMATION Audit Committee Dr. YAO Haixin (姚海鑫)(Chairman) Dr. CHOI Koon Shum (蔡冠深) Mr. ZHAO JOHN HUAN (趙令歡) Dr. CHEN LIAN YONG (陳連勇) Dr. FENG Xiaoyuan (馮曉源) Remuneration and Appraisal Committee Dr. FENG Xiaoyuan (馮曉源) (Chairman) Mr. WU Shaojie (武少傑) Dr. CHEN LIAN YONG (陳連勇) Dr.
    [Show full text]
  • A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer
    Published OnlineFirst June 15, 2017; DOI: 10.1158/2326-6066.CIR-16-0381 Title: A Four-Factor Immunoscore System that Predicts Clinical Outcome for Stage II/III Gastric Cancer Running Title: Immunoscore as Prognostic Model for Gastric Cancer Ti Wen1†PhD., Zhenning Wang2†MD., Yi Li3 MD., Zhi Li1 MD., Xiaofang Che1 PhD., Yibo Fan1 MD., Shuo Wang1 MD., Jinglei Qu1 MD., Xianghong Yang5 MD., Kezuo Hou1BS., Wenyang Zhou5 MS., Ling Xu1 MD., Ce Li1 MS., Jin Wang1 MD., Jing Liu1 MD., Liqun Chen3BS., Jingdong Zhang4 MD., Xiujuan Qu1* MD., Yunpeng Liu1* MD. 1 Department of Medical Oncology, Key Laboratory of Anticancer Drugs and Biotherapy of Liaoning Province 2 Department of Surgical Oncology and General Surgery, The First Hospital of China Medical University, No.155, Nanjing North Street, Heping District, Shenyang, 110001, China 3 Department of Pathology, 4 Department of Medical Oncology, Cancer Hospital of Liaoning Province, No.44, Xiaoheyan Road, Dadong District, Shenyang, 110042, China 5 Department of Pathology, Shengjing Hospital of China Medical University, No.36, Sanhao Street, Heping District, Shenyang, 110004, China *Corresponding Author: Yunpeng Liu, MD. PhD., Tel/Fax: +86-(0)24-83282312; E-mail: [email protected] and Xiujuan Qu, MD. PhD. Tel/Fax: +86-(0)24-83282312; E-mail:[email protected]; Department of Medical Oncology, The First Hospital of China Medical University, No.155, Nanjing North Street, Heping District, Shenyang 110001, China; †These two authors contributed equally to this work. Keywords: gastric cancer, immunoscore system, PD-L1, PD-1, CD8, prognostic model Grant Support This work was supported by Key National Science and Technology Major Project of China (No.
    [Show full text]
  • 2017 Annual Report 1 Definitions
    * Bank of Jinzhou Co., Ltd. is not an authorized institution within the meaning of the Banking Ordinane (Chapter 155 of the Laws of Hong Kong), not subject to the supervision of the Hong Kong Monetary Authority, and not authorized to carry on banking and/or deposit-taking business in Hong Kong. Contents 2 Definitions 4 Chapter 1 Company Profile 7 Chapter 2 Financial Highlights 10 Chapter 3 Chairman ’s Statement 12 Chapter 4 President’s Statement 14 Chapter 5 Management Discussion and Analysis 71 Chapter 6 Changes in Ordinary Shares and Particulars of Shareholders 77 Chapter 7 Particulars of Preference Shares 79 Chapter 8 Directors, Supervisors, Senior Management, Employees and Organizations 98 Chapter 9 Corporate Governance Report 119 Chapter 10 Directors’ Report 127 Chapter 11 Supervisors’ Report 130 Chapter 12 Social Responsibility Report 132 Chapter 13 Internal Control and Internal Audit 136 Chapter 14 Important Events 139 Chapter 15 Independent Auditor’s Report 149 Chapter 16 Financial Statements 269 Chapter 17 Unaudited Supplementary Financial Information Bank of Jinzhou Co., Ltd. 2017 Annual Report 1 Definitions In this annual report, unless the context otherwise requires, the following terms shall have the meanings set out below: “A Share Offering” the Bank’s proposed initial public offering of not more than 1,927,000,000 A shares, which has been approved by the Shareholders on 29 June 2016 “Articles of Association” the articles of association of the Bank, as the same may be amended from time to time “the Bank”, “Bank of Jinzhou”
    [Show full text]
  • STAFF APPRAISAL REPORT Public Disclosure Authorized
    INTERNATIONAL BANK FOR RECONSTRUCTION AND DEVELOPMENT STAFF APPRAISAL REPORT Public Disclosure Authorized China: Songliao Plain Agricultural Development Project June 16, 1994 The above-captioned Public Disclosure Authorized Staff Appraisal Report for China: Songliao Plain Agricultural Development Project is a revised version of the report prepared following the approval of the Project by the Executive Directors of the Bank and does not include information deemed confidential by the Public Disclosure Authorized Government of the People's Republic of China. Public Disclosure Authorized I Documentof The World Bank FOR OFFICIAL USE ONLY /3 77P-CAII- F, ~~~11`7?5=CHA STAFIFAPPRAISAL REPORT CHINA SONGLIAO PLAIN AGRICULTURAL DEVELOPMENT PROJECT February 1, 1994 INACCORDANCE WTH THE WORLD BAK'S POUCY D.OISCLOSURE OFINFORMATION TH16DOIC_WEHT ISAVAILABLE TO THE PUBL. Agriculture OperationsDivision / 7 China and Mongolia Department East Aia and Pacific Regional Office eY CURRENCY EQUIVALENTSI/ (January 1, 1994) Currency Unit - Yuan (Y) $1.00 = Y 8.7 Y 1.00 - $0.115 FISCAL YEAR January 1 - December 31 WIGHTS AND MEASURE I meter (m) 3.28 feet (ft) 1 cubic meter (m3) = 35.31 cubic feet I millimeter(mm) = 0.04 inch 1 kilometer (kIn) = 0.62 miles 1 square kdlometer(kmi 2) = 100 hectares 1 hectare (ha) 15 mu I ton (t) 1,000 kg = 2,205 pounds 1 kilogram (kg) = 2.2 pounds 1 kilovolt OMV) = 1,000 volts I ldlowatt (W) = 1,000 watts 1/ Thisproect W appraisdm lune/uly 1993whm the excane atewas $1 - Y 5.7. AUlcosts and finncinghve bee raculaed gtthe ateof $1 - Y 8.7,effective Januay 1, 1994.Economic and A finncial lysis baed onorigal pprisalparmiete.
    [Show full text]
  • Effect of Finger Pressing on Anti-Inflammatory Effect in Obese Rats with Insulin Resistance
    2021 International Conference on Biomedicine, Medical Services & Specialties (BMMSS 2021) Effect of Finger Pressing on Anti-Inflammatory Effect in Obese Rats with Insulin Resistance Shaotao Chen1, Lin JIANG2, Xiaolin Zhang1, Mingjun Liu1,* 1Changchun University of Traditional Chinese Medicine, Changchun, Jilin 130117, China 2Balipu Community Health Service Center, Erdao District, Changchun, Jilin 130117, China *Corresponding Author Keywords: Finger pressure method, Insulin resistance, Obese rats Abstract: Objective: To observe the anti-inflammatory effect of finger pressure method on obese rats with insulin resistance and study its mechanism. Methods: 20 male SD rats aged 5-8 weeks were randomly divided into two groups: general diet plus finger pressure method group and high fat plus finger pressure method group. They were fed with high fat diet for 8 weeks. The success of modeling was judged by fasting blood glucose, fasting insulin level and glucose tolerance test. The model of insulin resistance induced by obesity was induced by high fat diet for 8 weeks in the high fat plus finger pressure method group and the general diet plus finger pressure method group. After the experiment, blood glucose, blood insulin, TG, TCH, LDL and FFA were measured, and the fat- body ratio around testis and kidney was measured by killing animals. Results: The body weight, Lee index and fat coefficient of obese rats were significantly increased by high fat diet. Aerobic exercise and polysaccharide intervention can decrease the above morphological indexes. After 4 weeks of hypoxic exercise, the rats lost weight (P < 0.05), impaired glucose tolerance, insulin resistance and insulin sensitivity. The basic finger pressure method intervention can alleviate the anti-inflammation and improve the insulin resistance of obese rats.
    [Show full text]
  • Fu Shou Yuan International Group Limited 福壽園國際集團有限公司 (Incorporated in the Cayman Islands with Limited Liability) (Stock Code: 1448)
    Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement. Fu Shou Yuan International Group Limited 福壽園國際集團有限公司 (incorporated in the Cayman Islands with limited liability) (Stock Code: 1448) VOLUNTARY ANNOUNCEMENT STRATEGIC COOPERATION AGREEMENTS This is a voluntary announcement made by Fu Shou Yuan International Group Limited (the “Company”, together with its subsidiaries, the “Group”) for keeping the shareholders of the Company and potential investors informed of the latest business development of the Group. The board of directors (the “Board”) of the Company is pleased to announce that, on December 19, 2014, the Company entered into strategic cooperation agreements with each of the People’s Government of Hunnan District of Shenyang City* (瀋陽市渾南區人民政府)(“Shenyang City Hunnan District Government”) (“Shenyang Strategic Cooperation”) and the People’s Government of Jinzhou City* in Liaoning Province (遼寧省錦州市人民政府)(“Jinzhou City Government”) (“Jinzhou Strategic Cooperation”), in relation to the further development and cooperation in the death care services industry in the respective cities. SHENYANG STRATEGIC COOPERATION Under the Shenyang Strategic Cooperation, among other things, the Shenyang City Hunnan District Government will source potential funeral services development projects for the Company, which they will in return (i) provide due diligence support and feasibility analysis (ii) source investment funding and introduce high-technology funeral equipments and (iii) structure innovative service system, implement the Company’s business objectives and management expertise.
    [Show full text]
  • Printmgr File
    DEFINITIONS AND GLOSSARY In this prospectus, unless the context otherwise requires, the following terms shall have the meanings set out below: “Anci District Huimin Village and Huimin Village Bank Company Limited of Anci, Langfang Township Bank” ( ), a joint stock company with limited liability incorporated in the PRC on December 6, 2011, in which the Bank holds a 51% equity interest. The remaining nine shareholders hold 49% equity interest in Anci District Huimin Village and Township Bank “Anping Huimin Village and Township Anping Huimin Village Bank Co., Ltd. Bank” ( ), a joint stock company with limited liability incorporated in the PRC on December 24, 2013, in which the Bank holds a 36% equity interest. The remaining 30 shareholders hold 64% equity interest in Anping Huimin Village and Township Bank. The Bank and five other shareholders (holding an aggregate of 39.16% equity interest in Anping Huimin Village and Township Bank) entered into agreements to act in concert with respect to their voting rights to be exercised at board meetings and shareholders’ general meetings of Anping Huimin Village and Township Bank. Anping Huimin Village and Township Bank is deemed to be under the Bank’s control and to be the Group’s subsidiary “Application Form(s)” WHITE, YELLOW and GREEN application forms or, where the context so requires, any of them, relating to the Hong Kong Public Offering “Baicheng Taobei Huimin Village and Baicheng Taobei Huimin Village Bank Co., Ltd. Township Bank” ( ), a joint stock company with limited liability incorporated in the PRC on November 23, 2015, in which the Bank holds a 49% equity interest.
    [Show full text]
  • GIS-Based Spatial, Temporal, and Space–Time Analysis of Haemorrhagic Fever with Renal Syndrome
    Epidemiol. Infect. (2009), 137, 1766–1775. f Cambridge University Press 2009 doi:10.1017/S0950268809002659 Printed in the United Kingdom GIS-based spatial, temporal, and space–time analysis of haemorrhagic fever with renal syndrome W. WU 1, J.-Q. GUO 2, Z.-H. YIN 1,P.WANG3 AND B.-S. ZHOU 1* 1 Department of Epidemiology, School of Public Health, China Medical University, Shenyang, PR China 2 Liaoning Provincial Centre for Disease Control and Prevention, Shenyang, PR China 3 Shenyang Municipal Centre for Disease Control and Prevention, Shenyang, PR China (Accepted 23 March 2009; first published online 27 April 2009) SUMMARY We obtained a list of all reported cases of haemorrhagic fever with renal syndrome (HFRS) in Shenyang, China, during 1990–2003, and used GIS-based scan statistics to determine the distribution of HFRS cases and to identify key areas and periods for future risk-factor research. Spatial cluster analysis suggested three areas were at increased risk for HFRS. Temporal cluster analysis suggested one period was at increased risk for HFRS. Space–time cluster analysis suggested six areas from 1995 to 1996 and four areas from 1998 to 2003 were at increased risk for HFRS. We also discussed the likely reasons for these clusters. We conclude that GIS-based scan statistics may provide an opportunity to classify the epidemic situation of HFRS, and we can pursue future investigations to study the likely factors responsible for the increased disease risk based on the classification. Key words: Cluster analysis, geographical information system, HFRS. INTRODUCTION understanding of the spatial, temporal and space– time distribution patterns of HFRS would help in Haemorrhagic fever with renal syndrome (HFRS) is a identifying areas and periods at high risk, and might zoonosis caused by Hantaviruses from the family be very useful in surveillance of HFRS, discovering Bunyaviridae.
    [Show full text]
  • 錦州銀行股份有限公司 Bank of Jinzhou Co., Ltd
    英文版-左_6_OP.pdf 1 21/11/15 上午3:42 C M Y CM MY CY CMY K IMPORTANT If you are in any doubt about any of the contents of this prospectus, you should obtain independent professional advice. 錦州銀行股份有限公司 Bank of Jinzhou Co., Ltd.* (a joint stock company incorporated in the People’s Republic of China with limited liability) GLOBAL OFFERING Number of Offer Shares under the : 1,320,000,000 H Shares (comprising Global Offering 1,200,000,000 H Shares to be offered by our Bank and 120,000,000 Sale Shares to be offered by the Selling Shareholders, subject to the Over-allotment Option) Number of International Offer Shares : 1,188,000,000 H Shares (subject to adjustment and the Over-allotment Option) Number of Hong Kong Offer Shares : 132,000,000 H Shares (subject to adjustment) Maximum Offer Price : HK$5.54 per H Share, plus brokerage fee of 1%, SFC transaction levy of 0.0027% and Hong Kong Stock Exchange trading fee of 0.005% (payable in full on application in Hong Kong dollars and subject to refund) Nominal value : RMB1.00 per H Share Stock code : 416 Sole Sponsor Joint Global Coordinators Joint Bookrunners and Joint Lead Managers Hong Kong Exchanges and Clearing Limited, The Stock Exchange of Hong Kong Limited and Hong Kong Securities Clearing Company Limited take no responsibility for the contents of this prospectus, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this prospectus.
    [Show full text]
  • Table of Codes for Each Court of Each Level
    Table of Codes for Each Court of Each Level Corresponding Type Chinese Court Region Court Name Administrative Name Code Code Area Supreme People’s Court 最高人民法院 最高法 Higher People's Court of 北京市高级人民 Beijing 京 110000 1 Beijing Municipality 法院 Municipality No. 1 Intermediate People's 北京市第一中级 京 01 2 Court of Beijing Municipality 人民法院 Shijingshan Shijingshan District People’s 北京市石景山区 京 0107 110107 District of Beijing 1 Court of Beijing Municipality 人民法院 Municipality Haidian District of Haidian District People’s 北京市海淀区人 京 0108 110108 Beijing 1 Court of Beijing Municipality 民法院 Municipality Mentougou Mentougou District People’s 北京市门头沟区 京 0109 110109 District of Beijing 1 Court of Beijing Municipality 人民法院 Municipality Changping Changping District People’s 北京市昌平区人 京 0114 110114 District of Beijing 1 Court of Beijing Municipality 民法院 Municipality Yanqing County People’s 延庆县人民法院 京 0229 110229 Yanqing County 1 Court No. 2 Intermediate People's 北京市第二中级 京 02 2 Court of Beijing Municipality 人民法院 Dongcheng Dongcheng District People’s 北京市东城区人 京 0101 110101 District of Beijing 1 Court of Beijing Municipality 民法院 Municipality Xicheng District Xicheng District People’s 北京市西城区人 京 0102 110102 of Beijing 1 Court of Beijing Municipality 民法院 Municipality Fengtai District of Fengtai District People’s 北京市丰台区人 京 0106 110106 Beijing 1 Court of Beijing Municipality 民法院 Municipality 1 Fangshan District Fangshan District People’s 北京市房山区人 京 0111 110111 of Beijing 1 Court of Beijing Municipality 民法院 Municipality Daxing District of Daxing District People’s 北京市大兴区人 京 0115
    [Show full text]
  • Study on Revitalizing Northeast China Through a New Road of Industrialization
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by CSCanada.net: E-Journals (Canadian Academy of Oriental and Occidental Culture,... Canadian Social Science Vol.4 No.2 April 2008 Study on Revitalizing Northeast China Through a New Road of Industrialization ETUDE DE LA REVITALISATION DU NORD-EST DE CHINE PAR UNE NOUVELLE VOIE D’INDUSTRIALISATION Pei Pei1 Yang Fan2 Abstract: The old northeast industrial base has been the cradle of China after Liberation industry and has made the significant contribution to speed up the process of industrialization in China. The 16th National Party Congress definitely put forward the strategy of revitalizing the old industrial bases in Northeast China. Undoubtedly it can bring new lease and vitality for the development of the old industrial bases in Northeast China in the future. To begin with the study of the contents of a new road of industrialization, the article focuses on the necessity of taking a new road of industrialization to revitalize Northeast China and put forward the countermeasures for it according to analyze the current status. Key words: revitalization of Northeast China, new industrialization, resources, countermeasures Résumé: L’ancienne base industrielle nord-est a été le berceau de l’industrie de Chine après la Libération et a donné une contribution signifiante à l’accélération du processus d’industrialisation chinoise. Le 16e Congrès national du Parti a mis en avant définitivement la stratégie de revitalisation des anciennes bases industrielles dans le Nore-Est de Chine. Sans aucun doute, cette stratégie peut amener la vitalité et un nouveau commencement au développement des ces anciennes bases industrielles dans le futur.
    [Show full text]
  • The Role of Intestinal Microbiota and Mast Cell in a Rat Model of Visceral Hypersensitivity
    J Neurogastroenterol Motil, Vol. 26 No. 4 October, 2020 pISSN: 2093-0879 eISSN: 2093-0887 https://doi.org/10.5056/jnm20004 JNM Journal of Neurogastroenterology and Motility Original Article The Role of Intestinal Microbiota and Mast Cell in a Rat Model of Visceral Hypersensitivity Ying-Jie Li,1 Jing Li,1* and Cong Dai2* 1Department of Gastroenterology, First Affiliated Hospital, Jinzhou Medical University, Jinzhou, Liaoning, China; and 2Department of Gastroenterology, First Affiliated Hospital, China Medical University, Shenyang, Liaoning, China Background/Aims To explore the role of intestinal flora and mast cells in visceral hypersensitivity (VH). Methods The experimental animals were divided into 4 groups: control group, VH group, VH + VSL#3 group, and VH + ketotifen group. Stool samples were collected from each group (n = 3) for a further analysis using 16S ribosomal DNA gene sequence. Visceral sensitivity was evaluated by abdominal withdrawal reflex (AWR) score. Colon tissues of rats were obtained from each group. Mast cells were detected by toluidine blue staining. The degranulation of mast cells was assessed by transmission electron microscopy. Results VH rat model could successfully be induced by acetic acid enema combined with partial limb restraint method. Compared with rats in the control group, AWR score, number of mast cells, and degranulation of mast cells were increased in the VH rats, which could be reduced by administration of ketotifen or probiotic VSL#3. Clostridium sensu stricto 1 abundance was higher in the VH group compared to the control group, which could be restored by application of probiotic VSL#3. Conclusions Probiotic VSL#3 decreases visceral sensitivity in VH rats.
    [Show full text]